The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada

Hanley, Gillian E.; Morgan, Steve; Barer, Morris L.; Reid, Robert J.

doi:10.1016/j.healthpol.2010.12.005

Cited by 3 publications

(1 citation statement)

References 10 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The consolidation file is a comprehensive data set, containing information on individuals receiving health services and/or individuals eligible to receive health services in BC, Canada (˜4.6 million people). We used the consolidation data to access demographic data and information on registration for health insurance in BC, in order to assess whether a woman had moved out of BC [ 19 ]. As the data linkage maintained patient anonymity (all identifiers were removed before being provided to the researchers) and the population-based administrative datasets in BC operate based on passive consent (i.e.…”

Section: Methodsmentioning

confidence: 99%

Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada

et al. 2018

Self Cite

View full text Add to dashboard Cite

ObjectivesAmong women with epithelial ovarian cancer (EOC), histotype is one of the major prognostic factors. However, few data are available on histotype- specific survival and mortality estimates among these patients. We therefore examined survival and causes of death among women with EOC by histotype.MethodsA population- based cohort including all ovarian cancer patients diagnosed in British Columbia (BC) between 1990 and 2014 was built using population-based administrative datasets. We compared causes of death within histotypes, by age at diagnosis, BRCA status, and time since diagnosis.ResultsA total of 6975 women were identified as having been diagnosed with EOC between 1990 and 2014 in BC. The most common cause of death among these women was ovarian cancer until 10 years post diagnosis when other causes surpassed ovarian cancer as the leading cause of death. Among women with serous EOCs, ovarian cancer was the leading cause of death 12 years after diagnosis, whereas ovarian cancer was the leading cause of death for 8 years among women with non- serous EOCs. Among women with serous EOCs, ovarian cancer was the leading cause of death for 12 years among younger women (< 60 years of age) compared to 8 years among women > = 60 years of age, and those with BRCA mutations were more likely to die from ovarian cancer than those without a BRCA mutation.ConclusionsWithin 10 years from diagnosis, ovarian cancer is the leading cause of death among women diagnosed with EOC.Electronic supplementary materialThe online version of this article (10.1186/s12885-018-4970-9) contains supplementary material, which is available to authorized users.

show abstract

Section: Methodsmentioning

confidence: 99%